Buprenorphine-Precipitated Withdrawal Among Hospitalized Patients Using Fentanyl
In this retrospective cohort study, 11.5% of patients developed PW after buprenorphine initiation in ED or hospital settings. Future studies should confirm the rate of PW and assess whether bioaccumulated fentanyl is a risk factor for PW.
Authors
- Ashish P. Thakrar (ORCID: https://orcid.org/0000-0002-4406-6752)
- Margaret Lowenstein (ORCID: https://orcid.org/0000-0001-5450-6814)
- Sophia Faude
- Kyle M. Kampman (ORCID: https://orcid.org/0000-0002-9760-8324)
- Anthony Spadaro (ORCID: https://orcid.org/0000-0002-0941-4651)
- M. Kit Delgado (ORCID: https://orcid.org/0000-0002-2248-8401)
- Christopher K. Snider (ORCID: https://orcid.org/0000-0001-7064-4352)
- Jeanmarie Perrone (ORCID: https://orcid.org/0000-0001-7073-9060)
- Austin S. Kilaru (ORCID: https://orcid.org/0000-0002-3141-1772)
- Paul J. Christine (ORCID: https://orcid.org/0000-0003-1707-0761)
- Andrew Siaw-Asamoah
- Lewis S. Nelson (ORCID: https://orcid.org/0000-0001-9551-3922)
Institutions
- Rutgers, The State University of New Jersey (US)
- NYU Langone Health (US)
- Rutgers New Jersey Medical School (US)
- University of Colorado Anschutz Medical Campus (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2024-09-27
- DOI
- https://doi.org/10.1001/jamanetworkopen.2024.35895
- Citations
- 34
- Primary Topic
- Opioid Use Disorder Treatment
- Type
- article
- Field-Weighted Citation Impact
- 18.46
Funders
- National Heart, Lung, and Blood Institute
- National Institute on Drug Abuse